PsychoGenics: PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery

PsychoGenics a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, announced that it has launched eCube, a novel pharmaco-electroencephalography ("pharmacoEEG") platform to support phenotypic drug discovery, which unlike traditional target-based drug discovery, can identify novel treatments with multiple targets. Similar to the Company's AI-enabled, behavior-based platform, SmartCube eCube harnesses machine learning to identify [...]The post PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery appeared first on AiThority.